Long-term, open-label safety and tolerability study of once-daily extended-release oxcarbazepine (SPN-804) as adjunctive therapy in patients with refractory partial seizures

Authors
Category Primary study
JournalNeurology
Year 2013
This article has no abstract
Epistemonikos ID: 3346feb38fb397e0ad8e18f050350df15f1436f0
First added on: Feb 05, 2025